CGC Form 4: 45,680 RSUs Awarded to Director with Vesting Schedule
Rhea-AI Filing Summary
Canopy Growth Corp (CGC) reported a grant of 45,680 restricted stock units to director M. Shan Atkins on August 12, 2025. The RSUs were issued as compensation and will vest in three scheduled tranches: 10,578 RSUs on September 29, 2025, 17,551 RSUs on December 31, 2025, and 17,551 RSUs on March 31, 2026. The filing shows the reporting person is a director and the transaction was reported as an acquisition at no cash price. The Form 4 was signed by an attorney-in-fact on August 14, 2025, and provides the standard disclosure of beneficial ownership following the grant.
Positive
- 45,680 RSUs granted to director M. Shan Atkins, disclosed transparently on Form 4
- Defined vesting schedule: 10,578 RSUs vest 09/29/2025, 17,551 vest 12/31/2025, 17,551 vest 03/31/2026
Negative
- None.
Insights
TL;DR: A routine director equity grant with a clear vesting schedule, consistent with compensation alignment practices.
The filing documents a director-level equity award of 45,680 RSUs with defined vesting dates across late 2025 and early 2026, signaling use of time-based equity to align the director's interests with shareholder value over the near term. The Form 4 discloses direct beneficial ownership following the grant and is properly executed by an attorney-in-fact, indicating standard governance and disclosure procedures were followed.
TL;DR: Non-derivative RSU grant reported; transaction appears administrative and not immediately market-moving.
The Form 4 shows an acquisition code transaction of 45,680 common share-equivalent RSUs granted at $0 price, with tranche vesting on 09/29/2025, 12/31/2025, and 03/31/2026. The disclosure is concise and limited to compensation-related ownership change, with no exercise prices or derivative holdings reported. From a reporting standpoint, this is a routine insider compensation disclosure rather than a strategic corporate action.